https://www.stocktitan.net/overview/BMEA/
BMEA Stock Price, News & Analysis | Biomea Fusion
May 1, 2026 - Biomea Fusion, Inc. (BMEA) is a clinical-stage biopharmaceutical company developing oral small-molecule therapies for diabetes, obesity, and related metabolic...
stock price newsbmeaanalysisfusion